Search results
24 sie 2023 · Two new Alzheimer’s drugs are showing promising results of slowing the disease in the early stages. A new study reported that a new Eli Lilly drug, donanemab, slowed the progression of...
18 lip 2023 · In a short time, decades of research has started to come to fruition, with at least three new drugs demonstrating the first glimmers of promise. The latest is called donanemab, with the findings of a global trial involving 1,700 patients presented at a major Alzheimer's conference in The Netherlands.
3 paź 2024 · For the first time, scientists have developed a drug that works on both major aggregation-promoting 'hotspots' of the Tau protein in the brain -- a key driver of neurodegeneration. The drug, a...
28 maj 2024 · A recent study in Nature Medicine found that LM11A-31, targeting the p75 neurotrophin receptor, is safe and shows promise in slowing Alzheimer's disease progression.
5 wrz 2024 · In a recent breakthrough in Alzheimer’s disease research, Auburn University scientists have studied a new drug, troriluzole, that can prevent brain changes leading to memory loss and cognitive decline in a mouse model of the disease.
6 dni temu · In a new study, researchers created an algorithm to assess, in an unbiased manner, how well models of Alzheimer's disease mimic the function and gene expression patterns seen in patients' brains.
Researchers are preparing to test lecanemab with other experimental drugs, and how it works in high-risk people before they show the first signs of memory problems. An experimental Alzheimer’s...
